Familial Hypertrophic Cardiomyopathy

An autosomal dominant inherited form of HYPERTROPHIC CARDIOMYOPATHY. It results from any of more than 50 mutations involving genes encoding contractile proteins such as VENTRICULAR MYOSINS; cardiac TROPONIN T; ALPHA-TROPOMYOSIN.

Also Known As:

Cardiomyopathy, Familial Hypertrophic; Cardiomyopathy, Hypertrophic, Familial; Asymmetric Septal Hypertrophy, Familial; Hereditary Ventricular Hypertrophy; Hypertrophic Subaortic Stenosis, Idiopathic; Obstructive Asymmetric Septal Hypertrophy; Ventricular Hypertrophy, Familial; Ventricular Hypertrophy, Hereditary; Cardiomyopathies, Familial Hypertrophic; Familial Hypertrophic Cardiomyopathies; Familial Ventricular Hypertrophies; Familial Ventricular Hypertrophy; Hereditary Ventricular Hypertrophies; Hypertrophic Cardiomyopathies, Familial; Hypertrophic Cardiomyopathy, Familial; Hypertrophies, Hereditary Ventricular; Hypertrophy, Familial Ventricular; Hypertrophy, Hereditary Ventricular; Ventricular Hypertrophies, Familial; Ventricular Hypertrophies, Hereditary

Cardiovascular Diseases: 91362
- Heart Diseases: 26014
  - Cardiomyopathies: 19128
    - Hypertrophic Cardiomyopathy: 4931
      - Familial Hypertrophic Cardiomyopathy: 388
  - Heart Valve Diseases: 1865
    - Aortic Valve Disease: 802
      - Aortic Valve Stenosis: 7844
        Subvalvular Aortic Stenosis: 16
        Hypertrophic Cardiomyopathy: 4931
        Familial Hypertrophic Cardiomyopathy: 388
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
- Inborn Genetic Diseases: 11939
  - Familial Hypertrophic Cardiomyopathy: 388

Emily M Schulz Selected Research

Emily M Schulz Research Topics

Disease

Drug/Important Bio-Agent (IBA)